|
Acute coronary syndromes
Citations 481-490 of 961 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Distal Protection With a Filter Device During Coronary Stenting in Patients With Stable and Unstable Angina
- Annalisa Angelini, Paolo Rubartelli, Flavio Mistrorigo, Mila Della Barbera, Francesco Abbadessa, Massimo Vischi, Gaetano Thiene, and Sergio Chierchia
Circulation published July 26, 2004, doi:10.1161/01.CIR.0000137821.94074.EE
[Abstract]
- Editorials
Vulnerable Plaque: The Devil Is in the Details
- Zorina S. Galis
Circulation 2004;110:244-246, doi:10.1161/01.CIR.0000135195.60131.59
[Full text]
- Coronary Heart Disease
Coronary Artery Spatial Distribution of Acute Myocardial Infarction Occlusions
- John C. Wang, Sharon-Lise T. Normand, Laura Mauri, and Richard E. Kuntz
Circulation 2004;110:278-284; published online before print as doi:10.1161/01.CIR.0000135468.67850.F4
[Abstract]
[Full text]
- Articles
Fish Intake and Risk of Incident Atrial Fibrillation
- Dariush Mozaffarian, Bruce M. Psaty, Eric B. Rimm, Rozenn N. Lemaitre, Gregory L. Burke, Mary F. Lyles, David Lefkowitz, and David S. Siscovick
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000138154.00779.A5
[Abstract]
- Articles
Loading With 600 mg Clopidogrel in Patients With Coronary Artery Disease With and Without Chronic Clopidogrel Therapy
- Adnan Kastrati, Nicolas von Beckerath, Alexander Joost, Gisela Pogatsa-Murray, Olga Gorchakova, and Albert Schömig
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000137972.74120.12
[Abstract]
- Articles
Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study
- Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, William J. Sasiela, Michael Szarek, Peter Ganz, Peter Libby for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000136588.62638.5E
[Abstract]
- Editorials
Acute Coronary Syndrome Biomarkers: The Need for More Adequate Reporting
- Allan S. Jaffe and Hugo Katus
Circulation 2004;110:104-106, doi:10.1161/01.CIR.0000135581.79161.35
[Full text]
- Coronary Heart Disease
N-Terminal Pro-Brain Natriuretic Peptide on Admission Has Prognostic Value Across the Whole Spectrum of Acute Coronary Syndromes
- Marcello Galvani, Filippo Ottani, Luigi Oltrona, Diego Ardissino, Gian Franco Gensini, Aldo P. Maggioni, Pier Mannuccio Mannucci, Nicola Mininni, Maria Domenica Prando, Marco Tubaro, Arialdo Vernocchi, Carlo Vecchio on behalf of the Italian Working Group on Atherosclerosis, Thrombosis, and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri
Circulation 2004;110:128-134; published online before print as doi:10.1161/01.CIR.0000134480.06723.D8
[Abstract]
[Full text]
- Coronary Heart Disease
Inhibition of Platelet Adherence to Mononuclear Cells by  -Tocopherol: Role of P-Selectin
- Toyoaki Murohara, Hisao Ikeda, Yoritaka Otsuka, Mika Aoki, Nobuya Haramaki, Atsushi Katoh, Yoshinori Takajo, and Tsutomu Imaizumi
Circulation 2004;110:141-148; published online before print as doi:10.1161/01.CIR.0000134485.30393.63
[Abstract]
[Full text]
- Original Articles
Anti-Xa Activity Relates to Survival and Efficacy in Unselected Acute Coronary Syndrome Patients Treated With Enoxaparin
- G. Montalescot, J. P. Collet, M. L. Tanguy, A. Ankri, L. Payot, R. Dumaine, R. Choussat, F. Beygui, V. Gallois, and D. Thomas
Circulation published July 12, 2004, doi:10.1161/01.CIR.0000136830.65073.C7
[Abstract]
|
|
